Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production

One of the main challenges in gene therapy is the issue of delivery, and it is especially relevant for the success of gene therapy in the cornea. In the present work, eye drops containing biocompatible non-viral vectors based on solid lipid nanoparticles (SLNs) as gene delivery systems to induce the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Pharmaceutics
Главные авторы: Vicente-Pascual, Mónica, Gómez-Aguado, Itziar, Rodríguez-Castejón, Julen, Rodríguez-Gascón, Alicia, Muntoni, Elisabetta, Battaglia, Luigi, del Pozo-Rodríguez, Ana, Solinís Aspiazu, María Ángeles
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7355708/
https://ncbi.nlm.nih.gov/pubmed/32586018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12060584
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы